 Abstract :

There are several well-known benefits to using microparticulate drug delivery systems instead
of a single unit dose form. Among the most often used methods for creating microparticulate
medication delivery is microencapsulation. Even though it provides a lot of major benefits, but
only at the expense of some disadvantages. Some significant disadvantages of these methods
include the employment of severe conditions in the formulation process, which restricts the
number of substances that can be used as the main material for encapsulating, including
proteins, enzymes, and live cells. Making a drug delivery system out of microbeads is one way
to get over the above issue without using harsh chemicals or high temperatures. The traditional
methods include the utilization of polyelectrolyte complexation, ionotropic gelation, and
emulsion gelation. Due to its ease of preparation for the treatment of various diseases, the
majority of work has been done on the ionotropic gelation method of microbead preparation
rather than other methods. It will be interesting to evaluate the drug release pattern from
microbeads using various preparation techniques. In order to determine the best approach
among the many approaches, the current study aims to formulate and manufacture microbeads
utilizing a variety of procedures employing a drug that is soluble in water and compare the drug
release pattern of the prepared microbeads.

 Introduction :
Multiple unit dosage forms, such as microspheres or micro beads, have grown in popularity as
oral drug delivery systems because they provide more uniform drug distribution in the
gastrointestinal tract, more uniform drug absorption, less local irritation, and eliminate
unwanted intestinal retention of polymeric material when compared to non-disintegrating
single unit dosage forms. Microbeads are small, solid, and free-flowing particulate carriers that
carry dispersed medication particles in solution or crystalline form, allowing for prolonged or
multiple release profiles of treatment with various active agents without substantial side
effects.(1)
Beads can give prolonged release qualities and a more equal dispersion of medicines, including
the gastrointestinal tract. (2,3) Furthermore, the bioavailability of medications formulated in
beads has improved.(22) Microbeads are nearly spherical in shape and range in diameter from
0.5 to 1000 μm. The solid and free-flowing particulate carriers that contain dispersed
medication particles in crystalline or solution form allow for treatment with various active
agents with a variety of release profiles or a sustained release with few side effects.
Moreover, the microbeads continue to work in physiological conditions. Additionally, they can
be altered to incorporate drugs and administer them locally at high concentrations, guaranteeing
that therapeutic dosages are reached at the intended location and minimizing adverse effects
by keeping systemic quantities low. To make the microbeads, a number of polymers are mixed
in a specific ratio, including binding agents like gelatin, chondroitin sulfate, and avidin, cationic
polymers like chitosan, and anionic polymers like sodium alginate. (1,2) Microencapsulation
is a common technique used to create controlled release dosage forms. a process that uses a
controlled release formulation of different medicinal substances to create polymeric gel beads.
The beads are unique spherical microcapsules that serve as a solid substrate, with the
medication coated or encapsulated in the center. Beads can help drugs have sustained-release
 properties and be more evenly dispersed throughout the gastrointestinal tract. Additionally, the
bioavailability of drugs in bead packaging has improved. The use of alginate beads as a
controlled release carrier has been the focus of several published studies.(2)
The term "micro-beads" refers to a monolithic sphere that is spread throughout the matrix as a
molecular dispersion of particles, whereas "molecular dispersion" refers to the dispersion of
drug particles into the continuous phase of one or more miscible polymers.Interesting therapy
options for conditions including inflammation, arthritis, and asthma are provided by the gut
region's regulated systemic absorption.(3)

 Advantages :

1. The therapeutic effects of beads are long-lasting and consistent.

2. Reduces the frequency of doses, improving patient compliance.
3. Beads' spherical form and small size could be used to inject them into the body.
4. Improved medicine use will increase bioavailability and lessen the frequency or severity of
side effects.
5. Bead morphology allows for controlled variations in drug release and degradation.

 Disadvantages:
1.Manufacturing controlled pharmacological dosage forms is more expensive than producing
ordinary dosage forms.
2. Microspheres are difficult to replicate since their production necessitates specialized
knowledge and technologies.
3. Dose dumping could result in toxicity because microspheres contain large concentrations of
medications.
4. Additionally, polymeric additives like plasticizers, stabilizers, and antioxidants are utilized;
however, the formulation design will determine whether these polymers experience oxidation,
hydrolysis, or toxicity-causing reactions with biological agents.
5. Since the purpose of the oral administration microsphere is to prolong the release of
medication, it is best to swallow it rather than chew or crush it.
6. The stability of the medicine to be encapsulated can be affected by the microsphere
processing parameters, including pH, temperature, agitation, solvent evaporation, and
heating.(4,5,6)

 Polymers used for the Preparation of Microbeads

Numerous materials, both biodegradable and nonbiodegradable, have been studied for the
production of microbeads. These materials include modified natural compounds as well as
polymers of synthetic and natural origin. Examples of polymers include olyglycolide,
polyanhydride, polyphosphazene, albumin, gelatin, sodium alginate, chitosan, starch, dextran,
and polylactide. Sodium alginate micro beads are a type of multiparticulate drug delivery
system that can be used to target a drug to specific areas, increase stability or bioavailability,
 or provide delayed or controlled drug administration. When compared to non-disintegrating
single unit dosage forms, multiple unit dosage forms, like microspheres or beads, have become
more popular as oral drug delivery systems due to their reduced local irritation, more uniform
drug absorption, and elimination of undesired intestinal retention of polymeric material.(7)
 Cellulose:
Source:
The biological source of pure cellulose is cotton fiber, which is not used as food grade cellulose
but is typically utilized in chemical or pharmaceutical engineering. Hemp, corn, jute, rice, and
wheat straw are additional sources of cellulose.
Composition:
Plant cell walls are composed of pectin, cellulose, and hemicellulose. With the exception of the
terminal ends, each cellulose molecule has three hydroxyl groups per anhydro-D-
glucopyranose unit (AGU), making it an organic polymer composed of lengthy chains of AGU.
Applications:

➢ It is utilized in dressings and as a diluent/binder in tablets.

➢ It is utilized as a coating agent, ointment basis, and in a variety of medicinal

compositions.(8)
 Guargum:
The endosperm of the legume plant Cyamopsis tetragonolobus's seed is the source of guar gum.
Guar gum is prepared by physically separating the pods from the seeds after they have been
dried in the sun. Essentially, a mechanical process of roasting, differential attrition, sifting, and
polishing is used to commercially extract the gum from the seeds. The endosperm and germ
are separated, and the seeds are harmed. Guar Splits, which are obtained from each seed, are
half of the endosperm. With the help of sprucing, the good layer of fibrous material that makes
up the husk is removed and separated from the endosperm halves, resulting in delicate guar
splits. Depending on the desired end result, a variety of routes and processing methods are
subsequently used to treat and turn the fragile guar splits into powders. In terms of chemistry,
guar gum is a polysaccharide made up of mannose and galactose. Galactose residues are 1, 6-
linked to each 2d mannose to generate fast facet branches, while the backbone is a linear chain
of one, 4-related mannose residues. Guar gum has more galactose department points than locust
bean gum, making it more soluble and a higher emulsifier. At eighty-one pH and temperature
extremes (such as pH three at 50°C), it declines. Over a pH range of 5-7, it stays solid. Alkalis
in sturdy awareness also have a tendency to reduce viscosity, while sturdy acids produce
hydrolysis and lack of viscosity. In the majority of hydrocarbon solvents, it is insoluble.
Programs
It is used as a fat substitute that gives the "mouth experience" of fats, as well as a thickening in
sauces and cosmetics and to stop ice crystals from forming in ice lotions. Guar gum can be
utilized in the production of sustained release tablets as well as as a binder or disintegrator in
capsules.(13)
 Applications:

➢ Because certain enzymes in this area of the GIT may break down guar gum, it is mostly
helpful for colon delivery.

➢ Gum transports medication to targeted locations and shields it in the stomach and small
intestine. The polymer's primary function is to release sustainment.

➢ Because guar gum is a polymer that is mostly utilized as a sustain-releasing agent, it is

utilized as a carrier in medication delivery systems.
 Transdermal therapy methods are developed using carboxymethyl guar film as a thickening
and stabilizing component.(8)

 Agar:
Source
The dried gelatinous material known as agar, or agar-agar, is derived from Gelidium amansii
(Gelidaceae) and a number of other red algae species, including Pterocladia (Gelidaceae) and
Gracilaria (Gracilariaceae).

Composition:
Agar is a combination of agaropectin and agarose. Comprising the repeating monomeric unit
of agarobiose, agarose is a linear polymer. On the other hand, agarobiose is a disaccharide
composed of 3,6-anhydro-L-galactopyranose and D-galactose. The heterogeneous
combination of tiny acidic molecules that make up agaropectin does not gel well.

Applications:
There are several uses for agar, including as a laxative, emulsifying agent, gelling agent in
suppositories, surgical lubricant, pill disintegrant, and bacterial culture medium.
• In microbiology research, tissue culture investigations, and the production of jellies and
confections, it is also utilized.(14)

 Sodium Alginate:
Alginates are unbanked, linear polysaccharides made up of b-D mannuronic acid (M)
monomers and their C-5epimer a-l guluronic acid (G) residues connected by (1-4) glycoside
bonds. The residues are grouped in a pattern of blocks along the chain and typically differ
greatly in composition and sequence. The molecular weight and the breadth and makeup of the
sequences dictate the alginates' physical characteristics. Which organism and tissue the
alginates are derived from determines the molecular variability. An ionic polymer is formed
when thousands of oxidized sugar "units" come together to produce sodium alginate, a
polysaccharide. The units that recur are rings with six members that contain negatively charged
 CO2 groups. An oxygen atom connects the C-1 carbon atom of one ring to the C-4 carbon atom
of the subsequent ring in the polymer chain.
This natural polymer is very hydrophilic, or water-loving, due to the presence of ionic CO2
side chains and several OH groups. Many processed goods contain sodium alginate as a
"thickening agent." There are several applications for calcium and sodium alginate in the
pharmaceutical and medical sectors. It is used to diagnose and treat intestinal or gastric
disorders, as well as to manufacture dental impression materials, wound dressings, and
radiographic agents.

Applications :
1. It is reasonably priced and easily accessible.
2.It has components that are recognized as food additives.
3. It has a protective effect on the mucous membranes of the upper gastrointestinal system and
is non-toxic when taken orally.

4. It does not build up in any human organ and is hemocompatible.

5. Because it is biodegradable, surgical removal is not required when the medicine runs out.
6. In mild conditions, it can produce hydrogels.
7. Because it dissolves in water, it can reduce stability, toxicological issues, and environmental
problems related to solvents by eliminating the need for harmful solvents during processing.
(7)
 Starch :
Starch is a carbohydrate derived naturally from green plants, seeds, and underground plant
organs. Maize (Zea mays), rice (Oryza sativa), wheat (Triticumaestivum), and potatoes
(Solanum tuberosum) are all sources of starch used in various sectors. (9) Chemically, starch
is a carbohydrate composed of a long chain of glucose units connected together by glycosidic
bonds. Amylose is a non-branched helical polymer with long chains of α-1,4 connected D-
glucose monomers, while amylopectin is a highly branched polymer with long chains of both
α-1,4 and α-1,6 linked D-glucose monomers.(16)
Composition
Starch, also known as amylum, is a carbohydrate made up of several glucose units bonded
together by glycosidic linkages. Amylose is a non-branching helical polymer made of α-1,4
connected D-glucose monomers, while amylopectin is a highly branched polymer made of both
α-1,4 and α-1,6 linked D-glucose.(14,17)
Applications
Packaging, containers, mulch films, textile sizing agents, and adhesives all make use of
thermoplastic starch (14).
Starch is utilized in a variety of applications, including dilution, disintegration, binding,
absorbents, and glidants.
 ➢ Starch serves as an excipient in innovative drug delivery systems for nasal, oral, periodontal,
and other site-specific applications.

➢ Starch is utilized in topical medicines such as dusting powders due to its absorbent
properties. ➢ Used in ointments to protect the skin.

➢ Starch mucilage serves as an emollient(8)

 Carrageenan :
Carrageenan is a naturally occurring repeating unit of galactose and 3,6-anhydrogalactose high
molecular weight anionic gel-forming polysaccharide isolated from red seaweed species
including Euchema, Chondrus crispus, Iridaea, and Gigartina stellate.
Carrageenans are categorized into three categories based on their sulfation level: λ-carrageenan
(three-sulfate), κ-carrageenan (di-sulfate), and ι-carrageenan (monosulfate). Highly sulfated λ-
carrageenan is a thickening that does not form gel, whereas κ- and ι-carrageenan do, affecting
its release kinetics. Carrageenans are widely used in the food industry due to their excellent
physical functional qualities, which include bulking, thickening, stabilizing, and gelling. The
tablet's great durability, superior compatibility, and persistent viscoelasticity throughout
granulation and compression made it ideal as a tablet excipient. As a result, carrageenans make
excellent excipients for prolonged release formulations. Carrageenans' chemical reactivity
stems mostly from their half-ester sulfate groups, which are strongly anionic and so equivalent
to inorganic sulfate. The free acid is unstable, and commercial carrageenans are available as
stable sodium, potassium, and calcium salts, or, more typically, a blend of these.(7,13,17)
Applications:
• Pharmaceuticals: Encapsulation for controlled drug release and precise distribution.
• Food Industry: Thickening, stabilizing, and achieving gel-like textures in dairy, meat, and
dessert items.
• Biotechnology includes cell encapsulation for research, bioreactors, and tissue engineering.

• Agriculture: Encapsulating fertilizers and insecticides for slow release.

• Cosmetics: controlled release of active chemicals, biodegradable exfoliating particles. (7)
 Chitosan:
Sources: Chitosan, a naturally occurring polymer, can be produced by deacetylating chitin.(8)
Chitin is a white, rigid, inelastic mucopolysaccharide that supports crustaceans and insects. It
is a homopolymer composed of N-acetyl glucosamine units linked through a β (1-4) linkage,
with a 3D α-helical structure supported by hydrogen bonding. (7) Chitosan's major trait in
medication delivery is that it has a positive charge under acidic circumstances. This positive
charge approach comes from the protonation of the free amino groups.(12)
Chitosan is a linear polysaccharide made up of randomly dispersed β-(1-4)-connected D-
glucosamine (deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit).(13)

Applications:
 Chitosan nanoparticles and microparticles are also good candidates for controlled drug
release.(8)
Drug distribution through cationic complex formation with drug/excipient molecules.
Controlled drug release. (Gel-forming ability in low pH conditions, with high charge density
at pH < 6.5)

Fast-acting medication dosage forms

Peptide Delivery Adsorption Enhancer for Hydrophilic Drugs .(7)
 Gelatin:
The majority of commercial gelatin is made from mammalian bones (mostly bovine and
porcine) and other materials. To generate gelatin, enzymes hydrolyze collagen, the principal
protein component of skin, bones, and connective tissue in all animals, including fish and
insects. Gelatin can also be obtained with acid treatment, such as HCL or H2SO4, while gelatin
obtained through alkaline treatment is known as type B. After both treatments, the solutions
are filtered, deionized, and concentrated using vacuum evaporation and membrane filtration
methods.

Composition: Gelatin is a water-soluble proteinaceous substance formed by the breakdown of

endogenous collagens. It contains a considerable amount of glycine, proline, and 4-
hydroxyproline residues(14).
Applications :
Gelatin's capacity to bind water and produce gels makes it widely employed in the culinary,
pharmaceutical, and cosmetic sectors.

➢ Gelatin is used in tablet coatings to decrease dusting and cover undesirable tastes.

➢ Gelatin-based microencapsulated oils provide nutritional and therapeutic purposes.(8)

 Techniques for the preparation of beads :

 Ionotropic Gelation Method :
Ionotropic gelation is a commonly used process for producing sodium alginate beads. (19)
Ionotropic gelation is essentially the interaction of an ionic polymer with an oppositely charged
ion, which initiates cross linking.(21) Hydrogel beads can be produced in two ways using the
ionotropic gelation procedure. These procedures differ in the source of the cross-linking
ion.(23)
a. External Gelation Method. The external gelation approach employs a metal ion solution as
a source of the crosslinking ion. With gentle agitation, a needle is used to extrude the drug-
containing polymer solution into this solution. As soon as the polymeric drop comes into
contact with the metal ion solution, immediate gelation occurs, resulting in self-sustaining bead
production. The beads are cured for a set amount of time in the gelation medium before being
removed and dried. External gelation occurs due to the fast diffusion of cross-linker ions into
partially gelled beads.
 b. The Internal Gelation Method The internal gelation approach involves generating the cross-
linker ion 'in situ'. This approach makes use of an insoluble metal salt (such as calcium
carbonate or barium carbonate) as a source of crosslinking cation. In situ, the cation is released
by reducing the pH of the solution, which solubilizes the metal salt and releases the metal
ion.(20,23)
 Extrusion Spheronization:
The Extrusion Spheronization is a common and commonly used procedure for producing
uniform-sized pellets in numerous phases. Reynolds invented this technology in 1970, and
Conine Hadley also contributed to its development.(27)
Extrusion and Spheronization Process
Extrusion spheronization has five steps: mixing, extrusion, spheronization, coating, and drying.
Dry mixing of ingredients ensures homogeneous powder dispersion.

Ø Wet massing creates enough plastic mass.

Extrusion produces rod-shaped particles with consistent diameter.
Spheronization converts rod-shaped particles into spherical particles with a restricted size
distribution.
Ø Dry to reach desired moisture content.
Ø Screening to get appropriate sphere/pellet sizes. (24,25)
 Spray Drying :
Drug compounds in solution or suspension are sprayed with or without excipients into a heated
stream of air to produce dry spheroids. When atomized droplets come into contact with hot air,
the application media evaporates. This drying process continues through a series of stages in
which the viscosity of the droplets gradually increases until the entire application medium is
evaporated and solid particles are formed. The spray-dried powder particles are homogeneous
and uniform in size. The design and operation of the spray dryer can improve the properties of
the final pellet, such as particle size, particle distribution, bulk density, porosity, flow ability,
moisture content, and friability.(27)
 Emulsion Gelation Method :
Emulsion gelation procedures are another method of preparing microbeads.(20) Oil gel beads
were made by gently combining oil and water with sodium alginate and extruding them into a
calcium chloride solution.(30,31)
The sodium alginate solution was made by dispersing a weighed amount of sodium alginate in
deionized water. A precisely weighed amount of drug was introduced to a polymeric solution
of sodium alginate, and the drug was magnetically agitated with mild heat to form a
homogeneous drug-polymeric combination. A specific volume of cross-linking agent was
added to create a viscous dispersion, which was then extruded through a syringe with a flat-
tipped needle of size 23 into oil containing span 80 and 0.2% glacial acetic acid while being
magnetically stirred at 1500 rpm. The microbeads are left in the oil for 30 minutes to form stiff,
distinct particles. The microbeads were separated by decantation and washed with chloroform
to eliminate oil residues. They were then dried at 400ºC for 12 hours.(20)
 Polyelectrolyte Complexation Method :
The polyelectrolyte complexation process can also increase the quality of hydrogel beads made
using the ionotropic gelation method. The addition of oppositely charged second
polyelectrolyte to ionotropically gelled hydrogel beads can improve their mechanical strength
and permeability barrier.(32)
Another method of microbeads preparation is the complex coacervation of oppositely charged
polyelectrolytes, polycation and polyanion materials, alginate-chitosan microcapsules with
biocompatibility and biodegradability can be prepared under mild conditions, even
physiological conditions, so they are suitable for the application in biomedical fields.(7) In
recent years, there has been a growing interest in the investigation of alginate-chitosan
microcapsules as drug delivery vehicles for proteins and polypeptides. Under certain
parameters of polyion concentration, pH, and ionic strength, the liquid separates into a dense
coacertive phase containing the microbeads and a dilute equilibrium phase [8]. For example,
complicated coacervation of alginic acid and chitosan was achieved by spraying the sodium
alginate solution into the chitosan solution, resulting in robust microbeads that were stable
throughout a wide pH range. To achieve the optimum yield with coacervative bead preparation,
set the pH to 3.9, the ionic strength to 1 mM, and the total polyion content to 0.15% w/v.(20)

 Evaluation Parameters :
 Preformulation studies of drug :
Prior to the formulation of any dosage form, the medication and polymer must be identified
and characterized. Many preformulation parameters are utilized to determine its characteristics
and purity, including melting point, calibration plot, drug scanning, and IR investigations.(39)
Qualitative Evaluation:
Quantitative evaluation of formulation parameters included drug content, % yield, moisture
content, bulk density, tapped density, and Carr's index.(35)
Angle of Repose:

The powder's flow characteristics are gauged by its angle of repose. It is the greatest angle
formed between the powder pile's surface and the horizontal plane. The formula was used to
calculate the angle of repose. The finely ground mucilage was transferred to graph paper using
a funnel, with the funnel's height kept constant. By measuring the height and base of the powder
pile that developed and applying an equation, the angle of repose was then determined in
accordance with the USP.
tan θ = h/r:

θ = tan-1 (h/r)
where H is the height in centimeters and
θ is the angle of repose.
R is base/radius in centimeters.
Bulk Density (BD):
This is the proportion of the powder's bulk volume to its overall mass. Weigh a 50 g amount of
powdered mucilage precisely, then transfer it to a 100 ml graduated cylinder. The initial
apparent volume (Vo) of mucilage was determined by carefully leveling the mixture.
It is possible to compute the loose bulk density using the formula g/ml
ρ b = M / Vb.

where M is the blend's bulk weight,

Vb is its bulk volume, and
ρb is its bulk density.
Tapped Density:
The ratio of the powder's total mass to its tapped volume is known as the "tapped density"
(TD). Weigh out 40 grams of the powder combination precisely, then transfer it to a 100
milliliter measuring cylinder. After physically tapping the sample-containing cylinder three
times (1250, 750, and 500), the final tapped volume (Vf) was measured. Using a formula, the
taped bulk density may be determined and represented in g/ml.
ρ t = M / Vt
where Vb is the blend's tapped volume,
M is its weight, and
ρt is its tapped density.
Index of Compressibility (Carr's Index)
The ratio of the difference between the tapped and bulk densities is known as the
compressibility index. It gauges the flowability of powder and is given as a percentage:
Using (Dt - Db / Dt)*100, Carr's Index (%)

where Db is the powder's bulk density and

Dt is its tapered density.
Hausner’s Ratio :
One metric that is associated with a powder or granular material's flowability is the Hausner
ratio. It is a measure of how easy it is for powder to flow.
= ρ b / ρ t is the Hausner Ratio.

where ρ t is the powder's bulk density and

ρ b is its taped density. (42)
Degree Of Swelling :
Swelling studies was
performed in a water bath shaker at 37 ± 0.2
C. Pre-weighed beads were placed in a phosphate buffer (pH 7.4)
and allowed to swell. Beads were removed at various time intervals, blotted with filter paper
to remove excess water and their change in weights were recorded until an equilibrium weight
was achieved. The degree of swelling was calculated by:
Degree of swelling (%)=( Wf -Wi) / Wf *100
where Wi is the initial weight of beads before swelling, Wf is the final weight of beads at
equilibrium swelling(37)
Efficiency of encapsulation = (AQ/TQ) X 100
where TQ is the theoretical amount of drug present in beads and AQ is the actual drug content
of beads.(38)
Drug Excipient Compatibility Studies :
The Differential Scalorimeter (DSC) and FTIR were used in drug polymer compatibility tests.
After storing the drug and various polymer mixture in a vial at room temperature for a month,
the samples are examined, and the findings are interpreted.(39)
Percentage Yield :
The initial weight of the raw material and the end weight of the solid dispersion-entrapped
alginate beads can be used to calculate the percentage yield.
The formula Percentage yield = Practical yield / Theoretical yield x 100 can be used to
determine percentage yield.
Drug Content and Percentage Entrapment Efficiency:
10mg of ivacaftor solid dispersion entrapped alginate beads were weighed, put into a beaker,
mixed with 10ml of 0.1N HCl, and agitated for 15 minutes with a glass rod. The mixture was
then left overnight. The following day, the solution was once more agitated for fifteen minutes,
and a UV spectrophotometer was used to measure absorbance at 255 nm. Entrapment efficiency
and drug content were computed using absorbance.
The percentage of drug content is equal to the ratio of theoretical to practical drug content x
100. %
Weight of original drug − weight of final drug/weight of first drug times 100 is the entrapment
efficiency. (40)
In Vitro Dissolution Studies :
The microspheres were subjected to in-vitro dissolution rate experiments utilizing the USP XX
type-II (electro lab TDP-06T) apparatus21. 900ml of 7.2 pH phosphate buffer at 37±0.5ºC and
100 rpm was used to study drug release. At regular intervals, 1 ml of the sample was taken out
and replaced with the same amount of freshly heated dissolving medium. A Shimadzu 1700
UV visible spectrophotometer was used to perform a spectrophotometric analysis on the
extracted materials at 320 nm.(35)
Buoyancy Studies :
By measuring buoyancy and the amount of time needed to sink each bead under investigation,
the floating characteristics of beads were investigated. In order to replicate the surface tension
of human stomach juice, a surfactant was added to the medium. All of the formulations' beads
floated right away (with very little lag time) and continued to do so for 24 hours.(38)
UV Spectrophotometric Analysis of Drug:
 UV analysis can be used to determine the drug's maximal wavelength. Following the
preparation of an appropriate drug solution in several media, the drug's maximum wavelength
in each medium was determined using UV spectrometry and compared to a standard.(39)
Fourier Transfer Infrared Spectroscopy :
To find out if the medicine and the selected flavor masking agents interact, the FTIR spectra of
pure PRD, taste masking agents, the ideal taste masking formula, and its PM were analyzed.
These spectra were acquired by employing infrared spectroscopy (Shimadzu, Japan) to scan
the 400–4000 cm-1 range.(41)

 Applications :
Oral Drug Delivery
The oral route is a simple and practical way to administer the medication, and patients are more
likely to comply with it. A significant number of pharmacological medications are delivered
orally. The drug's permeability and solubility are the primary determinants of oral absorption.
The prolonged and regulated drug release provided by microsphere drug delivery lowers the
frequency of doses and increases patient compliance.(4)
Gene Delivery
Microspheres' ability to stick and move through the GI tract makes them a potential oral gene
carrier. As an example, consider chitosan, gelatin, viral vectors, cationic liposomes, polycation
complexes, gene therapy using DNA plasmids, and insulin delivery. Given that a vaccine's
requirement is defense against the microbe or its harmful byproduct, it is also advantageous in
the administration of vaccines. One potential solution to the drawbacks of traditional vaccines
is the use of biodegradable delivery systems for parenterally administered vaccines. A number
of parenteral vaccines, such as the tetanus and diphtheria vaccine, have been encased in
biodegradable polymeric microspheres. (6)
Repeating units of substances-based API Delivery Systems
The bioavailability and residence times of the API in the nasal passage are improved by
substances like particles, lipoid systems, and gels, which have been shown to have high
bioadhesive qualities and can readily develop size when in contact with the nasal skin. such as
gelatin, poliglusam, and starch. (9)
Monoclonal Antibodies
Targeting microspheres, also known as monoclonal antibodies, are biologically immunological
microspheres that are used to selectively target organ locations. Through direct coupling,
coupling via reagents, or non-specific or specific adsorption, they facilitate absorption by
binding particularly to particular molecules.(11)
Mucoadhesive Delivery
Because it avoids the liver's first-pass metabolism, this method is suitable for the buccal and
sublingual routes, which can work quickly and have higher bioavailability compared to simple
oral delivery. (12)
Ocular Drug Delivery
For the delivery of drugs into the eyes, microspheres are an excellent carrier. Compared to
aqueous ocular preparations, the medication's bioavailability has been enhanced through the
use of microspheres for drug administration. Microspheres are employed for the long-lasting
release of drugs because of their regulated or sustained release mechanism, which lowers the
frequency of dosage.(4)
Intranasal Drug Delivery
For the delivery of proteins and peptides, this method is mostly recommended. The nasal
mucosa readily drains conventional formulations. Better bioavailability is achieved by
bioadhesive microspheres through their controlled and sustained method. (4)
Gastrointestinal Drug Delivery
When placed in acidic and neutral solutions, polymer granules with de-acidified interior
cavities—such as eudragit, ethyl cellulose + carbopol BSA, and gelatin—are found to float and
release the medicine in a regulated manner.
Intra-tumoral and local drug delivery
Anticancer medications, such as paclitaxel-loaded microspheres, should be administered at an
incorrect concentration to the tumor site. To maintain the release at the local site—the oral
cavity—filmforming polymers are utilized.
Colonic drug delivery
The medicine is delivered to the colon, a particular location in the bowel, using microspheres.
Chitosan microspheres containing insulin are designed to deliver the medication at the colon.
(4)
Application in dentistry
Microspheres are used in dental preparations to treat gingivitis and bleeding gums, among other
oral cavity illnesses. Additionally, microspheres are employed in the regeneration of
craniofacial tissue.
Medical Application
Protein, peptide, and hormone release over an extended period of time;
active targeting of tumor cells and antigens via parenteral route; and
passive targeting of leaky tumor vasculature.
Magnetic microspheres are used for a variety of diagnostic tests for infectious diseases,
including bacterial, viral, and fungal ones;
they can also be utilized for bone marrow purging and stem cell extraction.
Radioactive Application
Numerous liver and spleen cancers that are embolized for radio synoviectomy or local
radiation, arthritis, liver and bone marrow imaging, and even thrombus imaging in deep vein
thrombosis can benefit from it.
 Conclusion :
The current review states that new developments in drug delivery are making it possible to
incorporate pharmaceutically active ingredients into various dosage forms. The market for
these innovations is also developing at an impressive rate, which means that there will be a lot
of therapeutic and commercial returns. By encapsulating the active pharmaceutical ingredients
into spheres using natural polymers, multiparticulate drug delivery systems (Beads) offer the
ability to control and delay the release of the drug; as a result, beads have a number of technical
and physical advantages. Additionally, beads help doctors and product development
researchers become more flexible and adaptive, which advances therapeutic optimization.
Researchers will have a better understanding of beads as a microparticulate drug delivery arena
thanks to the features of polymers, bead fabrication technologies, and assessment
characteristics offered in this paper. Microbeads will play a key role in novel drug delivery in
the future by combining a number of different approaches, including diseased cell sorting,
diagnostics, gene and genetic materials, safe, targeted, specific, and efficient in-vivo delivery,
and supplements that function as miniature representations of the body's diseased organs and
tissues.

 References :

1. Menon, T. V., & Sajeeth, C. (2013). Formulation and evaluation of sustained release sodium
alginate microbeads of carvedilol. Research Journal of Pharmacy and Technology, 6(4), 392–
397.
2. Moinuddin, N. S. K., M, N. P. K., G, N. S. K., Ramya, N. P., Sree, N. K. S., & K, N. K. (2024).
A review on micro beads: Formulation, technological aspects, and extraction. GSC Biological
and Pharmaceutical Sciences, 26(2), 059–066.
3. Kaur, G., & Paliwal, S. (2019). FORMULATION AND EVALUATION OF ETORICOXIB
MICROBEADS FOR SUSTAINED DRUG DELIVERY. Universal Journal of
Pharmaceutical Research.
4. Mousami S Samanta*, Deepak Gautam, Muhammed Wasim Chandel, Gaurang Sawant, Kirti
Sharma. A review on microspheres as a novel controlled drug delivery system. Asian journal
of pharmaceutical and clinical research 2021 Feb 13 ;15(4): 3-11
5. Kakkar, V., Wani, S. U. D., Gautam, S. P., & Qadrie, Z. L. (2020). ROLE OF MICROSPHERES
IN NOVEL DRUG DELIVERY SYSTEMS: PREPARATION METHODS AND
APPLICATIONS. International Journal of Current Pharmaceutical Research, 10–15.
6. Pharmaceutical application of microspheres : An approach for the treatment of various
diseases. International Journal of Pharmaceutical Sciences and Research 2017 July 19; 8(8):
3252-3260.
7. Bhupathyraaj, M., Pole, S., Vijayarani, R., & Essa, M. (2021). ROLE OF POLYMERS IN
SUSTAINED RELEASED MICROBEADS FORMULATION: A REVIEW. International
Journal of Pharmaceutical Sciences and Research, 12(1). https://doi.org/10.13040/ijpsr.0975-
8232.12(1).76-84
8. Pal, M. S., & Waikar, S. B. (2023). Natural Excipients used for Formulation of Pharmaceutical
Beads. International Journal of Pharmaceutical Sciences Review and
Research, 81(1). https://doi.org/10.47583/ijpsrr.2023.v81i01.003
9. Bidgar N.N., Pawar R.H., Chakole, R. D., Burade K.B., Charde M.S. An Overview: Sustained-
Release Sodium Alginate Beads. International Journal of Pharmacy and Pharmaceutical
Research. 2021 june 30; 21(3): 884-907.
10. Nkjj
11. A Review on microspheres : Types, Formulation Methods, Characterization and Application.
International Journal of Novel Research and Development 2024 June 6; 9(6): b470-b485.
12. Subramani, M., Vekatashwaramurthy, N., & Sambathkumar, R. (2021). A Novel Approach on
Role of Polymers Used in Sustained Release Drug Delivery System- a review. Saudi Journal
of Medical and Pharmaceutical Sciences, 7(4), 170–
178. https://doi.org/10.36348/sjmps.2021.v07i04.002
13. Laxmi Sanjabrao Deshmukh , Damini Anil Mundhare , Disha Prakash Wankhede , Shravan S.
Swarkar, Sayyed Tohid Syyed Hakeem , Mohammad Tausif Shaikh Qayyum , Nandakishor
Deshmukh, Dr. Swati Deshmukh. Polymer Used In Pharmaceticals Formulation. International
Journal of Creative Research Thoughts 2023 Oct 10: 11(10): 378-388.
14. Kusum Kaushik*, Ram Babu Sharma, Shweta Agarwal.Natural Polymers and their
Applications . International Journal of Pharmaceutical Sciences review and research. 2016
April 31; 37(2); 30-36.
15. Sangeetha, K., Kumari, A. V. J., Radha, E., & Sudha, P. N. (2019). Pharmaceutical applications
of collagen. In Apple Academic Press eBooks (pp. 61–
92). https://doi.org/10.1201/9780429328350-3
16. Aggarwal, D., & Minocha, N. (2020). NATURAL POLYMERS: THEIR APPLICATIONS IN
FOOD, COSMETIC AND PHARMACEUTICAL INDUSTRIES. International Journal of
Advanced Research, 8(5), 1224–1238. https://doi.org/10.21474/ijar01/11037
17. Kulkarni Vishakha S* , Butte Kishor D and Rathod Sudha S. Natural Polymers – A
Comprehensive Review. International Journal of Research in Pharmaceutical and Biomedical
Sciences. 2012 Dec; 3(4): 1597-1613.
18. Troy, E., Tilbury, M. A., Power, A. M., & Wall, J. G. (2021). Nature-Based biomaterials and
their application in biomedicine. Polymers, 13(19),
3321. https://doi.org/10.3390/polym13193321
19. Sayali S Shelar*, Dr Rajendra K Surawase. Formulation Techniques And Modern Methods For
Sodium Alginate Beads: Chemical Characterization. International Journal of Creative Research
Thoughts (IJCRT). 2024 Aug ; 12(8): b937-b942.
20. Umesh D. Shivhare*, Vijay B. Mathur, Chandrashekhar G. Shrivastava, Vivek I. Ramteke;
Preparation of Microbeads by different Techniques and Study of their influence on Evaluation
Parameters; J. Adv. Pharm. Edu. & Res. 2013: 3(3): 279-288.
21. Ms. Sayali S. Shelar , Mr. Rajendra K. Surawase , Mr. Omraje A. Jadhav , Mr. Yogesh S. Purkar
, Mr. Shubham P. Bhadane. Recent Advances In Formulation Techniques And Evaluation
Methods For Sodium Alginate Beads: A Review. International Journal of Creative Research
Thoughts (IJCRT). 2024 April; 12(4): o35o49.
22. Khazaeli, P., Pardakhty, A., & Hassanzadeh, F. (2008). Formulation of ibuprofen beads by
ionotropic gelation. Iranian Journal of Pharmaceutical Research, 7(3), 163–
170. https://doi.org/10.22037/ijpr.2010.761
23. Ahirrao, S. P., Gide, P. S., Shrivastav, B., & Sharma, P. (2014). Ionotropic gelation: a promising
cross linking technique for hydrogels. Research and Reviews : Journal of Pharmaceutics and
Nanotechnology, 2(1), 1–6. https://www.rroij.com/open-access/ionotropic-gelation-a-
promising-cross-linking-technique-for-hydrogels-1-6.pdf
24. Nagasamy Venkatesh Dhandapani*, Ayush Shrestha, Niroj Shrestha, Anup Thapa, Goti Sandip,
Rajan Sharma Bhattarai. Pelletization by Extrusion-Spheronization: A detailed review. All Res.
J. Biol. 2012 Oct ; 3(2): 10-23.
25. Shyamala Bhaskaran, Lakshmi.P.K. Extrusion Spheronization –A Review. International
Journal of PharmTech Research. 2010 Dec; 2(4): 2429- 2433.
26. Łętocha, A., Miastkowska, M., & Sikora, E. (2022). Preparation and characteristics of alginate
microparticles for food, pharmaceutical and cosmetic applications. Polymers, 14(18),
3834. https://doi.org/10.3390/polym14183834
27. A, R. B., S, G. N., & Chandy, V. (2019). A STUDY ON DIFFERENT PELLET FORMATION
TECHNIQUES AND ITS EVALUATION PARAMETERS-A REVIEW. International Journal
of Current Pharmaceutical Research, 7–13. https://doi.org/10.22159/ijcpr.2019v11i2.33020
28. Funfakjit, N., Kanana, N., Manopakdee, K., & Charnvanich, D. (2024b). Preparation of
alginate beads by ionic gelation method using Encapsulator B-390: Effect of process
parameters on physical properties of beads. Thai Journal of Pharmaceutical
Sciences, 48(3). https://doi.org/10.56808/3027-7922.2971
29. Gadziński, P., Froelich, A., Jadach, B., Wojtyłko, M., Tatarek, A., Białek, A., Krysztofiak, J.,
Gackowski, M., Otto, F., & Osmałek, T. (2022). Ionotropic gelation and chemical crosslinking
as methods for fabrication of Modified-Release GELLAn Gum-Based drug delivery
systems. Pharmaceutics, 15(1), 108. https://doi.org/10.3390/pharmaceutics15010108
30. Maya Sharma, Kajal Jain, Suresh Kumar Dev, P. K. Choudhury. Formulation and Evaluation
of Sodium Alginate Beads by Emulsion Gelation Method. Asian Journal of Pharmaceutics.
2017 Jan ; 11(1): s101-s106.
31. Smriti Malviya , Jitendra Pandepy, Sumeet Dwivedi. Formulation and evaluation of floating
microbeads of Ciprofloxacin HCl by emulsion gelation method. International Journal Of
Pharmacy & Life Sciences. 2013 Aug; 4(8): 2876-2884.
32. J.S. Patil* , M.V. Kamalapur, S.C. Marapur, D.V. Kadam. Ionotropic Gelation And
Polyelectrolyte Complexation: The Novel Techniques To Design Hydrogel Particulate
Sustained, Modulated Drug Delivery System: A Review. Digest Journal of Nanomaterials and
Biostructures. 2010 March; 5(1) : 241-248.
33. Li, W., Chen, W., Wang, Z., Chen, W., Zhang, M., Zhong, Q., Pei, J., & Chen, H. (2022).
Preparation and Characterization of Beads of Sodium Alginate/Carboxymethyl
Chitosan/Cellulose Nanofiber Containing Porous Starch Embedded with Gallic Acid: An In
Vitro Simulation Delivery Study. Foods, 11(10), 1394. https://doi.org/10.3390/foods11101394
34. Eleti Bunny Priya , Dr. T. Rama Rao. A Review on Preparation and Evaluation of Sodium
Alginate Beads with Metformin. International Journal of Novel Research and Development.
2024 Jan; 9(1): d256-d259.
35. Jharana Mallick ,Debashrita Sahoo, Durga Madhab Kar and Jagruti Makwana. Alginate Beads
Of Ibuprofen For Oral Sustained Drug Delivery: An In Vitro Evaluation. International Journal
Of Pharmaceutical, Chemical And Biological Sciences. 2013; 3(3): 595-602.
36. R.B.Desi Reddy,*Malleswari.K, Prasad.G, D. Prasanna. Preparation and In Vitro Evaluation of
Lamivudine Floating Sodium Alginate Beads. International Journal of Pharmaceutical and
Clinical Research. 2012 Dec; 4(4): 81-88.
37. Ansari, M., Sadarani, B., & Majumdar, A. (2018b). Colon targeted beads loaded with
pterostilbene: Formulation, optimization, characterization and in vivo evaluation. Saudi
Pharmaceutical Journal, 27(1), 71–81. https://doi.org/10.1016/j.jsps.2018.07.021
38. Rasel, M. a. T., & Hasan, M. (2012). Formulation and evaluation of floating alginate beads of
diclofenac sodium. Dhaka University Journal of Pharmaceutical Sciences, 11(1), 29–
35. https://doi.org/10.3329/dujps.v11i1.12484
39. Yashika Uniyal, Manoj Kumar Sarangi, Kriti Dabral. Formulation And Evaluation Of
Microbeads For Colon Targeted Drug Delivery Using Natural Polymer. World Journal Of
Pharmaceutical And Medical Research. 2019 June 12; 5(7): 153-163.
40. Kalpana, G. B., Bhaskar, N. V., Khan, K. a. A., & Prakash, P. R. (2021). Formulation,
optimization and evaluation of gastroretentive alginate beads of IVacAftor by using factorial
design. Journal of Clinical and Pharmaceutical Research, 16–
25. https://doi.org/10.61427/jcpr.v1.i2.2021.22
41. Ali, H. M. S., & Al-Khedairy, E. B. H. (2023). Formulation and evaluation of prednisolone -
Loaded alginate beads for taste masking. The Egyptian Journal of Hospital Medicine, 90(2),
2178–2186. https://doi.org/10.21608/ejhm.2023.285683
42. Yashika Uniyal, Manoj Kumar Sarangi, Kriti Dabral. Formulation And Evaluation Of
Microbeads For Colon Targeted Drug Delivery Using Natural Polymer. World Journal Of
Pharmaceutical And Medical Research. 2019 June 12; 5(7): 153-163.